Browsing by Subject "Y10S 514/913"

Now showing items 1-5 of 5

    • Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye 
      Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1984-07-10)
      Compositions for treating open-angle glaucoma comprising N,N-dimethylaminoethyl carbamate and method of treating ocular hypertension by topically administering such compound to the hypertensive eye.
    • Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones 
      Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1986-01-21)
      Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of a dopamine ...
    • Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma 
      Chiou, George C. Y.; Liu, Hsin-Kuang (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1985-06-04)
      Antiglaucoma compositions that contain enriched R-(+)-1-tert-butylamino-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-prop anol compared to the S-(-)-isomer and the ophthalmologically acceptable acid addition salts thereof ...
    • Treatment of low pressure glaucoma and ischemic retinal degeneration 
      Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-10-12)
      The invention relates to a method for increasing blood flow to the retina and choroid in subjects with decreased retinal or choroidal blood flow. The method involves the topical administration of metoclopramide and is ...
    • Treatment of ocular hypertension and glaucoma with dopamine antagonists 
      Chiou, George C. Y. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1988-09-20)
      Aqueous humor formation and intraocular pressure in mammals having ocular hypertension or glaucoma may be reduced by topically administering to a hypertensive eye an ophthalmologically acceptable amount of certain dopamine ...